SEC Company Response from Cue Biopharma, Inc. (CUE) (CIK 0001645460) (CUE) — Dec 13, 2017
Cue Biopharma, Inc. (CUE) (CIK 0001645460)
Date: Dec. 13, 2017 · CIK: 0001645460 · Accession: 0001571049-17-008699
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-220550
Letter
Cue Biopharma, Inc.
675 W. Kendall Street
Cambridge, MA 02142
December 13, 2017
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Irene Paik
Re: Cue Biopharma, Inc.
Registration Statement on Form S-1
File No. 333-220550
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, registrant Cue Biopharma, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective at 4:00 p.m., Eastern Time, on Thursday, December 14, 2017, or as soon thereafter as is practicable.
In connection with the foregoing request, the Company acknowledges that (i) should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely,
/s/ Gary Schuman
Show Raw Text
CORRESP 1 filename1.htm Cue Biopharma, Inc. 675 W. Kendall Street Cambridge, MA 02142 December 13, 2017 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Irene Paik Re: Cue Biopharma, Inc. Registration Statement on Form S-1 File No. 333-220550 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, registrant Cue Biopharma, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective at 4:00 p.m., Eastern Time, on Thursday, December 14, 2017, or as soon thereafter as is practicable. In connection with the foregoing request, the Company acknowledges that (i) should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Sincerely, /s/ Gary Schuman Gary Schuman Chief Financial Officer